Fortress Biotech Inc (FBIO)
1.625
+0.02
(+0.93%)
USD |
NASDAQ |
Oct 04, 16:00
1.625
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Shareholders Equity (Annual): 22.54M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.54M |
| December 31, 2022 | 41.72M |
| December 31, 2021 | 108.67M |
| December 31, 2020 | 100.34M |
| December 31, 2019 | 26.22M |
| December 31, 2018 | 1.852M |
| December 31, 2017 | 52.57M |
| Date | Value |
|---|---|
| December 31, 2016 | 38.50M |
| December 31, 2015 | 56.85M |
| December 31, 2014 | 70.52M |
| December 31, 2013 | 81.28M |
| December 31, 2012 | 22.03M |
| December 31, 2011 | 19.13M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
22.54M
Minimum
2023
108.67M
Maximum
2021
59.90M
Average
41.72M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Journey Medical Corp | 20.35M |
| Checkpoint Therapeutics Inc | -13.05M |
| Avenue Therapeutics Inc | 1.582M |
| Phathom Pharmaceuticals Inc | -72.76M |
| NovaBay Pharmaceuticals Inc | 3.314M |